ELEVANCE HEALTH INC (ELV) Institutional Ownership Changes & 13F Activity

ELEVANCE HEALTH INC (ELV). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings. This page analyzes institutional buying and selling activity, new holdings, and sold-out positions among tracked filers. Notable filers include Brave Warrior Advisors, First Eagle U.S. Value, Vulcan Value Partners, Eagle Capital Management, and Renaissance Technologies LLC.

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q3 2025Hancock Classic ValueSell-567216,709$70,023,012
Q2 2025Brave Warrior AdvisorsSell-467,9171,109,653$431,610,631
Q2 2025Baupost GroupBuy370,000616,000$239,599
Q2 2025Vulcan Value PartnersSell-85,143293,731$123,827,013
Q2 2025Renaissance Technologies LLCSell-69,40053,573$20,837,754
Q2 2025First Eagle U.S. ValueSell-41,2153,200,146$1,244,728,893
Q2 2025Sequoia FundSell-27,2651,095,655$426,165,969
Q2 2025Hancock Classic ValueBuy16,296217,276$84,511,673
Q2 2025Eagle Capital ManagementSell-10,3981,574,950$612,592,695
Q2 2025Yacktman Asset ManagementSell-1,128341,340$132,767,606
Q2 2025Sequoia Financial AdvisorsBuy1636,880$2,675,995
Q2 2025Dodge & Cox Stock FundBuy1001,300$505,648
Q1 2025Baupost GroupBuy246,000246,000$107,000
Q1 2025Brave Warrior AdvisorsSell-52,4071,577,570$686,179,847
Q1 2025Sequoia FundSell-21,0331,122,920$488,425,283
Q1 2025Eagle Capital ManagementBuy20,7321,585,348$689,562,966
Q1 2025First Eagle U.S. ValueBuy16,0223,241,361$1,409,862,551
Q1 2025Vulcan Value PartnersSell-15,018378,874$164,734,177
Q1 2025Hancock Classic ValueBuy6,983200,980$87,418,261
Q1 2025Sequoia Financial AdvisorsBuy9136,717$2,921,677
Q1 2025Yacktman Asset ManagementBuy435342,468$148,959,881
Q1 2025Lountzis Asset ManagementSell-177755$312,434
Q1 2025Dodge & Cox Stock FundBuy1001,200$521,952
Q4 2024First Eagle U.S. ValueBuy1,039,6123,225,339$1,189,827,627
Q4 2024Sequoia FundBuy139,4201,143,953$422,004,262
Q4 2024Renaissance Technologies LLCBuy115,000122,973$45,364,740
Q4 2024Vulcan Value PartnersBuy114,607393,892$145,233,542
Q4 2024Eagle Capital ManagementSell-35,6141,564,616$577,186,842
Q4 2024Brave Warrior AdvisorsSell-11,4361,629,977$601,298,515
Q4 2024Hancock Classic ValueBuy1,629193,997$71,565,493

Frequently asked questions about ELV activity

  • Which institutional owners are buying ELV?

    Institutional owners buying ELV include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in ELV activity?

    "Buy" means an investor increased their reported position in ELV compared to the prior reporting period. This reflects growing exposure to ELEVANCE HEALTH INC (ELV) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in ELV increasing?

    Institutional interest in ELV can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.

Related ELV Institutional Insights